VA

Valink Therapeutics

YC W21

Boston, US · Founded 2021 · 15 employees · 4 known investors

valinktx.com ↗

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

Founders & leadership· Y Combinator alumni (W21)

Arne ScheuinFounder

Irsyad KhairilinFounder

Investors · 4

Y

Y CombinatorMountain View · $500K – $500K

HO

Hoxton VenturesreportedLondon · $500K – $5M

LO

LongeVCreportedNewark

RE

redalpinereportedSwitzerland